Vinod Parameswaran MD MRCP FRCPath

PubMed

• 7 citations
  Safety and efficacy of fedratinib in patients with myelofibrosis previously treated with ruxolitinib: primary analysis of FREEDOM trial.
  Vikas Gupta, Abdulraheem Yacoub, Ruben A Mesa, Claire N Harrison, Alessandro M Vannucchi
  Leukemia & Lymphoma. 2024-09-01
• 2 citations
  Atovaquone-Proguanil: A Promising Therapy for Persistent Relapsing Babesiosis.
  Mahum Shahid, Brendan Wechsler, Vinod Parameswaran, Mark Anthony Diaz
  Case Reports in Infectious Diseases. 2024-01-01
• 33 citations
  Leukapheresis guidance and best practices for optimal chimeric antigen receptor T-cell manufacturing.
  Muna Qayed, Joseph P McGuirk, G Doug Myers, Vinod Parameswaran, Edmund K Waller
  Cytotherapy. 2022-09-01

Abstracts/Posters

• An Algorithm to Facilitate Successful and Cost Effective Hematopoietic Progenitor Cell (HPC) Harvests Based on Peripheral Blood HPC CD34 Counts
  Parameswaran R et al, February 2014Biology of Blood and Marrow Transplantation 20(2):S133-S134
• Autologous Transplantation as Consolidation Therapy for Primary CNS Lymphoma- A Single Center Experience
  Ramakrishnan Parameswaran et al, ASTCT, 2/1/2013
• Zoledronic Acid for the Prevention of Skeletal Complications In Patients with Multiple Myeloma: Interim Analysis Results of the Z-MARK Study
  Zoledronic Acid for the Prevention of Skeletal Complications In Patients with Multiple Myeloma: Interim Analysis Results of the Z-MARK Study Noopur Raje, MD, Robert V..., Blood (2010) 116 (21): 2971., 11/19/2010

Lectures

• Sally Frank Memorial Award and Lectureship: SBB Training Program Research Projects: Overview and Practical Examples 
  AABB Annual Meeting and CTTXPO 2013-Denver - 10/12/2013

Other

• The Bridge to Transplantation in Patients with Myelodysplastic Syndrome and Acute Myeloid Leukemia 
  Vinod Parameswaran, Blood and Marrow Transplantation Reviews
  http://www.bloodline.net/wp-content/uploads/2006/11/BMTR_16.3.pdf
  Hawaii - 2006